Clincosm LogoSign in Get a demo

Overweight

Showing NaN - NaN of 31
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Overweight, Obesity Trial in United States (pramlintide acetate, sibutramine, phentermine)

Completed
  • Overweight
  • Obesity
  • pramlintide acetate
  • +3 more
  • Birmingham, Alabama
  • +15 more
Mar 5, 2015

Obesity, Overweight Trial in United States (Naltrexone SR 32 mg/ bupropion SR 360 mg/ day, Placebo, Intensive group lifestyle

Completed
Has Results
  • Obesity
  • Overweight
  • Naltrexone SR 32 mg/ bupropion SR 360 mg/ day
  • +2 more
  • La Jolla, California
  • +8 more
Dec 2, 2014

Obesity, Overweight Trial in United States (Naltrexone SR 32 mg/bupropion SR 360 mg/day, Placebo, Ancillary therapy)

Completed
Has Results
  • Obesity
  • Overweight
  • Naltrexone SR 32 mg/bupropion SR 360 mg/day
  • +2 more
  • Phoenix, Arizona
  • +35 more
Nov 18, 2014

Type 2 Diabetes, Overweight, Obesity Trial in United States (Weight Watchers modified program, Standard Care group)

Completed
  • Type 2 Diabetes
  • +2 more
  • Weight Watchers modified program
  • Standard Care group
  • Birmingham, Alabama
  • +14 more
Oct 14, 2014

Overweight, Obesity Trial in New York (L-Leucine 8gr, Liquid meal, L-Leucine 4g)

Completed
Has Results
  • Overweight
  • Obesity
  • L-Leucine 8gr
  • +2 more
  • New York, New York
    Columbia University Medical Center
Mar 4, 2013

Type 2 Diabetes, Overweight Trial in United States (TANTALUS(TM) System)

Terminated
  • Type 2 Diabetes Mellitus
  • Overweight
  • TANTALUS(TM) System
  • La Jolla / San Diego, California
  • +9 more
Dec 15, 2010